NCT00730678Recruiting
Pharmacogenetic Determinants Of Treatment Response In Children
Source: ClinicalTrials.gov · Last updated 5 Nov 2026
Brief summary (registry, in English)
To investigate whether genetic polymorphisms in genes encoding proteins involved in the metabolism or effects of drugs or environmental agents influence the disposition or effects of these xenobiotic substrates. To investigate the nature of heritability and the genetic basis of pharmacogenetic traits by studying family members of individuals with specific genotypes.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 8800 (estimated)
- First submitted
- 6 Aug 2008
- Start date
- 17 Aug 1998
- Primary completion date
- Dec 2033
- Lead sponsor
- St. Jude Children's Research Hospital
- Diseases
- Childhood cancers
- NCT number
- NCT00730678
What you commit to
- Study type: Observational
- Planned participants: 8800
- From 17 Aug 1998 to the primary completion date, Dec 2033
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Who the study is looking for
- Any patients under evaluation/treatment at St. Jude Children's Research Hospital (SJCRH)
- Parents or family members of St. Jude patients
- Non patient volunteers
- All study subjects must provide informed consent for participation
- Assent/Consent of the patient (parent) must be provided prior to attempts made by investigators to enroll a family member of a SJCRH patient
Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| St. Jude Children's Research Hospital Coordinator of this site? Confirm its status | Memphis | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.